| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/14/2007 | CN1911396A Method for controlling quality injection contg. traditional Chinese medicine |
| 02/14/2007 | CN1911395A Method for controlling quality of injection contg. traditional Chinese medicine |
| 02/14/2007 | CN1911394A Method for controlling quality of injection contg. traditional Chinese medicine |
| 02/14/2007 | CN1911393A Injection contg. traditional Chinese medicine, and its quality control method |
| 02/14/2007 | CN1911392A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911391A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911390A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911389A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911388A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911387A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911386A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911385A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911384A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911383A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911382A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911381A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911380A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911379A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911378A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911377A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911376A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911375A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911374A Injection contg. traditional Chinese medicine, and its pren. method |
| 02/14/2007 | CN1911373A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911372A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911371A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911370A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911369A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911368A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911367A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911365A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911333A Process for extraction of peel of banana |
| 02/14/2007 | CN1911327A Decoction of herbal medicine for treating deficiency of live and kidney type cirsocele, and its preparing method |
| 02/14/2007 | CN1911325A Medicine prepn. for removing stagnate pulse-restoring |
| 02/14/2007 | CN1911289A Compound medicine contg. musk |
| 02/14/2007 | CN1911288A Compounding traditional Chinese medicine-Xueyaping for treating primary hypertension, and its prepn. method |
| 02/14/2007 | CN1911275A Traditional Chinese medicine composition used for treating brain apoplexia sequela |
| 02/14/2007 | CN1911274A Medicine for treating obstruction of qi in the chest, and its prodn. method |
| 02/14/2007 | CN1911273A Fingerprint atlas detection method for powder injection contg. high content of tanshin polyphenolic acid salts |
| 02/14/2007 | CN1911272A Powder injection contg. high content tanshin polyphenolic acid salts, and its prepn. method |
| 02/14/2007 | CN1911257A Extractive of ginkgo tree leaves, prepn. method and application thereof |
| 02/14/2007 | CN1911251A Traditional Chinese medicine enteric oral liquor using fresh earthworm extractive as active component, and its prepn. method |
| 02/14/2007 | CN1911250A Traditional Chinese medicine enteric oral liquor using leech extractive as active component, and its preparation method |
| 02/14/2007 | CN1911230A Cancer treatment |
| 02/14/2007 | CN1911222A Clonidine, weekly-effect, skin-permeable and control-released plaster |
| 02/14/2007 | CN1911221A Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 02/14/2007 | CN1911219A Medicine composition, and its application for treating diseases of cardiovascular and cerebrovascular |
| 02/14/2007 | CN1300293C Process for preparing hygienic medicated wine |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300171C Preparation of myocardium peptide |
| 02/14/2007 | CN1300164C Method for extracting vitexin, use and preparation |
| 02/14/2007 | CN1300161C Yellow pigment of safflower preparation method and application |
| 02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
| 02/14/2007 | CN1300113C Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2007 | CN1300111C Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 02/14/2007 | CN1299759C Chinese medicine composition for treating dizziness and its preparing and quality control method |
| 02/14/2007 | CN1299743C Pressure lifting oral administration liquor of astragalus root |
| 02/14/2007 | CN1299741C Chinese traditional medicine preparation for treating coronary heart disease and process for preparing the same |
| 02/14/2007 | CN1299733C Chinese medicine and its preparing method and use |
| 02/14/2007 | CN1299729C Medicinal plaster for treating angiocardiopathy |
| 02/14/2007 | CN1299718C Medicine for treating cardio-cerebral vascular disease and its preparing method |
| 02/14/2007 | CN1299717C Pharmaceutical composition for treating cerebral apoplexy and its preparation method |
| 02/14/2007 | CN1299706C Medicine for treating thrombosis type apoplexy |
| 02/14/2007 | CN1299700C Chinese traditional medicine for eliminating arteriosclerosis plaque |
| 02/14/2007 | CN1299690C Compositions for improving cardiovascular function |
| 02/14/2007 | CN1299687C Ointment for treating vein impairment |
| 02/14/2007 | CN1299683C Celecoxib compositions |
| 02/14/2007 | CN1299672C Extracts from sophora,production method and purposes thereof |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176224 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity |
| 02/13/2007 | US7176204 Substituted carboxylic acid derivatives |
| 02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
| 02/13/2007 | US7176197 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 02/13/2007 | US7176194 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/13/2007 | US7176193 Antilipemic agents; therapy for insulin resistance |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | CA2361288C Mutual prodrug of amlodipine and atorvastatin |
| 02/13/2007 | CA2358840C Methods and kits comprising an estrogen agonist/antagonist for improving vascular health |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/13/2007 | CA2266378C Use of sibutramine analogues to lower lipid levels |
| 02/13/2007 | CA2254759C Inhibitors of prenyl transferases |
| 02/13/2007 | CA2219947C Monoclonal antibody reactive to human cetp and assay method for human cetp |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/08/2007 | WO2007016563A2 Alcohol resistant pharmaceutical formulations |
| 02/08/2007 | WO2007016525A2 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 02/08/2007 | WO2007016354A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/08/2007 | WO2007015567A1 Cyclic amine compound |
| 02/08/2007 | WO2007015003A2 Novel crystalline iii form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 02/08/2007 | WO2007015002A2 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 02/08/2007 | WO2006114774A3 Pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 02/08/2007 | WO2006085631A3 Novel method for treating chronic severe heart failure by using insulin-like growth factor-1 (igf-1) |
| 02/08/2007 | WO2006078422A3 Methods for modulating tumor growth and metastasis |
| 02/08/2007 | WO2006055526B1 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032543 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients |